Medical Device News Magazine

Peter Eckes, Former CTO of BASF Agricultural Solutions, to Chair Harpe Bioherbicide Board

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Dr. Peter Eckes

Harpe Bioherbicide Solutions, Inc., an agricultural technology company focused on providing natural and sustainable herbicide solutions, announced today that Dr. Peter Eckes, former President of BASF leading Crop Protection R&D, Seed and Trait R&D and Regulatory in the Agricultural Solutions division, has joined its board and will serve as board chairperson.

Bill Buckner, CEO of Harpe Bioherbicide

“We’re thrilled to bring Peter’s vast, global experience developing and delivering innovation to our mission of creating new, natural weed control options for farmers and consumers.”

Through more than a 30-year career in the agricultural industry, Dr. Peter Eckes provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

“Harpe has both a compelling value proposition and strong business plan to bring new and natural weed control innovations to life,” said Eckes. “I look forward to supporting and accelerating Harpe’s efforts to meet the critical need for the next generation of weed control and consumer demands for more natural inputs.”

Eckes assumes board leadership from Aidan J. Connolly, President of AgriTech Capital, who will remain as a Harpe Bioherbicide board member.

“As important as it is for a start-up to have a laser focus, fresh perspectives can make all the difference in the world,” said Connolly. “I’m working closely with Peter to ensure we make the most of his leadership and build on the momentum Harpe has achieved.”

Additional Board Members

Additional Harpe Bioherbicide board members include CEO Buckner; Kip Tom, CEO of Tom Farms and former UN Ambassador; Robb Fraley, former CTO for Monsanto Co.; Chad Brommer, Harpe Bioherbicide co-founder and CTO; and Daniel Pepitone, Harpe Bioherbicide co-founder and COO.

In addition to serving as Board chair, Eckes will lead the company’s scientific advisory committee, which includes Adrian Percy, Executive Director of the N.C. Plant Sciences Initiative at North Carolina State University; Stephen Powles, Professor at University of Western Australia; and Wesley Everman, Associate Professor and Extension Weed Specialist at North Carolina State University.

Through wide-spectrum control of broadleaf and grass seeds or weeds, the platform of Harpe Bioherbicide products will deliver new opportunities for organic agriculture through a series of all natural herbicide formulations for pre, post and desiccation use patterns. In addition, a series of tailored Harpe Bioherbicide pre and tank mix formulations will improve control of tough-to-kill weeds, including those resistant to current synthetic chemistries, facilitating the reduction, replacement, and enhancement of synthetic herbicides used in row and specialty crop, and commercial markets.

This year’s BioAgTech World Congress will be in Raleigh, April 23-26. 2024. Harpe is a candidate for the BioAgTech Innovator Award and World Congress Wi-Fi sponsor. Approximately 1300 attendees from 250 companies and 60 countries will be in attendance. Those attending are invited to visit Booth #22 to learn more about Harpe Bioherbicide formulations.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”